Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 14,024

Document Document Title
WO/2011/158178
The instant invention relates to a method of determining whether to administer to a patient dronedarone, or a pharmaceutically acceptable salt thereof, in combination with a potassium-depleting diuretic for the treatment of arrhythmia co...  
WO/2011/158249
Disclosed is a process for the preparation of milnacipran intermediate, a compound of formula ΙII, and its use in the preparation of pure milnacipran.  
WO/2011/158333
The present invention provides a method for synthesizing a zederone analogue derived from natural materials, a precursor useful in synthesis of the zederone analogue, and an intermediate useful for synthesizing the zederone precursor. Sp...  
WO/2011/156321
Provided herein are substituted furanyl compounds of formula (I), pharmaceutical compositions comprising the compounds, methods of their preparation, and methods of their use. The compounds provided herein are useful for the treatment, p...  
WO/2011/153866
3-(o-Methylphenyl)-2-oxo-1-oxaspiro[4,5]-dec-3-en-4-ol derivatives shown as formula (I) with insecticidal, acaricidal and fungicidal activities and their preparation methods are disclosed, in which R are the following substitutes.  
WO/2011/156321
Provided herein are substituted furanyl compounds of formula (I), pharmaceutical compositions comprising the compounds, methods of their preparation, and methods of their use. The compounds provided herein are useful for the treatment, p...  
WO/2011/156655
Compounds that bind the glucagon-like peptide 1 receptor (GLP-1) receptor are provided including compounds which are modulators of the GLP-1 receptors and compounds which are capable of inducing a stabilizing effect on the receptor for u...  
WO/2011/153923
A process for preparing dronedarone or pharmaceutically acceptable salts thereof. The process comprises reacting 5-amino-2-butyl-3-(4-[3-(dibutylamino)propoxy]benzoyl) benzofuran (compound A) with methanesulfonyl chloride without any cat...  
WO/2011/153865
Disclosed are 3-ortho-methylphenyl-2-oxo-1-oxaspiro[4,4]non-3-en-4-ol of formula (I), derivatives and preparation method thereof, wherein (II) is described as the description. The compounds of formula (I) can be used as pesticides, acari...  
WO/2011/153502
The invention provides novel compositions based on a structure designated as "Honaucin A", including Honaucin A variants and analogs, and pharmaceutical compositions, liposomes and nanoparticles comprising them, and methods of making and...  
WO/2011/151442
A new route of synthesis of the compound Aliskiren of formula (I), used in the treatment of hypertension, is described.  
WO/2011/151442
A new route of synthesis of the compound Aliskiren of formula (I), used in the treatment of hypertension, is described.  
WO/2011/151348
This invention relates to heterocyclic amino acid derivatives suitable for labeling or already labeled with 18F or 19F, methods of preparing such compounds, compositions comprising such compounds, kits comprising such compounds or compos...  
WO/2011/153502
The invention provides novel compositions based on a structure designated as "Honaucin A", including Honaucin A variants and analogs, and pharmaceutical compositions, liposomes and nanoparticles comprising them, and methods of making and...  
WO/2011/149938
Processes for the synthesis of (3aS,7aR)-hexahydroisobenzofuran-1-(3H)-one, comprising comprising enzymatic hydrolysis of dimethyl cyclohexane-1,2-dicarboxylate to form (1S,2R)-2-(methoxycarbonyl) cyclohexanecarboxylic acid. The enzyme c...  
WO/2011/148909
Disclosed is an organic electroluminescent element which comprises: a positive electrode; a negative electrode; and at least a hole transport layer, a first light emitting layer, a second light emitting layer and an electron transport la...  
WO/2011/149938
Processes for the synthesis of (3aS,7aR)-hexahydroisobenzofuran-1-(3H)-one, comprising comprising enzymatic hydrolysis of dimethyl cyclohexane-1,2-dicarboxylate to form (1S,2R)-2-(methoxycarbonyl) cyclohexanecarboxylic acid. The enzyme c...  
WO/2011/149341
The invention is directed to a process for the treatment of lignocellulosic biomass to recover one or more components or derivatives of components thereof, said process comprising treating said biomass at a temperature of at least 75°C ...  
WO/2011/145048
The present invention relates to the use of a compound of having the following formula: wherein either 1 or 2 of the dotted lines represent a double bond, in order to provide or enhance buttery, creamy, green, fatty and/or milky note to ...  
WO/2011/146182
Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof, wherein E, X, G, W2 and Z are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods...  
WO/2011/145669
Disclosed are the compound represented by formula (I) which is useful as a therapeutic or prophylactic agent for various partial and/or generalized epileptic seizures, or a salt thereof. [In the formula, ring A and ring B independently r...  
WO/2011/145022
Compounds of Formula I that inhibit microsomal triglyceride transfer protein (MTP) and/or apolipoprotein B (Apo B) secretion and their uses in the treatment of diseases linked thereto in animals are described herein.  
WO/2011/146577
Functionalized polymer matrix and/or reinforcement materials that are capable of a thermoreversible Diels-Alder reaction are useful for making composite materials. Also disclosed is a composite material which includes one or both of func...  
WO/2011/145352
A process for the preparation of optically active cyano compounds, which includes a step of reacting an α,β-unsaturated compound having a prescribed structure with a cyanating agent in the presence of a titanium-containing catalyst tha...  
WO/2011/142466
Provided is an epoxy resin composition which produces a cured product having a low melt viscosity, excellent fluidity, and also excellent flame-retarding performance, adhesiveness, and heat resistance. The epoxy resin composition compris...  
WO/2011/142009
Disclosed is a preservative for preserving wood comprising 5-methyl-2-trifluoromethylfuran-3-carboxylic acid anilide derivative represented by formula (A), wherein R represents an isopropyl group or an isopropoxy group, as an active ingr...  
WO/2011/141458
The present invention refers to compounds of formula (I), as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer, aging related di...  
WO/2011/140998
Aralkyl diamine derivatives of the following formula, pharmaceutically acceptable salts or uses thereof as antidepressant. The derivatives have triplex inhibiting activities on the reuptake of 5-HT, dopamine and noradrenalin, which can b...  
WO/2011/140334
The present invention provides various compounds, compositions, and methods. In some embodiments, provided compounds have activity as, for example, inhibitors of protein translation.  
WO/2011/138956
Disclosed is a compound shown by general formula (C) having hypoxic environment selective growth inhibiting activity in a wide range of concentrations and having usefulness as an active ingredient in a preventative or therapeutic drug fo...  
WO/2011/140334
The present invention provides various compounds, compositions, and methods. In some embodiments, provided compounds have activity as, for example, inhibitors of protein translation.  
WO/2011/138665
The present invention provides dihydroorotate dehydrogenase inhibitors of formula (I), methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorde...  
WO/2011/134468
Novel biaryl compounds with phosphodiesterase inhibitory activity of the general formula (I), wherein R1, R2, R3, X, Y, Z1, Z2, Z3, and Z4 have the meanings defined herein, as well as their use as therapeutic agents in the treatment of i...  
WO/2011/136484
Provided are novel organic electroluminescent compounds and an organic electroluminescent device using the same. Since the organic electroluminescent compound exhibits high luminous efficiency in blue color and excellent life property, i...  
WO/2011/136059
A novel stable 10,10-dialkylanthrone compound is provided.  
WO/2011/136385
The present invention provides to a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metab...  
WO/2011/134538
A novel class of diyne compounds and diyne salts provided herein are effective and potent Ole1 protein inhibitors, useful for treating fungal pathogens. Compounds, fungicides and methods are provided as novel, potent and broad spectrum a...  
WO/2011/132712
Provided is a novel compound that is useful as a medical drug in that said compound displays strong antimicrobial activity against gram-negative bacteria such as Pseudomonas aeruginosa and drug-resistant strains thereof, on the basis of ...  
WO/2011/131102
Disclosed is a preparation method of a sphaelactone which is prepared form parthenolide sphaelactone as raw material and a suitable acid as catalyst in suitable solvent at suitable reaction temperature and the yield is more than 60%. Als...  
WO/2011/133659
Inhibitors of the Hypoxia Inducible Factor (HIF) and angiogenesis and their methods of use including the treatment of cancer, hypoxia related pathologies, disorders leading to ischemia, for example stroke and ischemic heart disease, and ...  
WO/2011/132051
The present invention provides Phosphodiesterase- 10 inhibitors. In particular, tricyclic derivatives described herein are useful as Phosphodiesterase- 10 inhibitors. Also provided herein are processes for preparing compounds described h...  
WO/2011/131103
Disclosed are sphaelactone derivatives of formula (I) or salts, their pharmaceutical compositions, preparation methods and uses for preparing anti-cancer drugs.  
WO/2011/131135
Heteroaryl (alkyl) dithiocarbamate compounds represented by general formula (I) or their pharmaceutical salts, their preparation methods and their uses for preparing antitumor medicines are disclosed, wherein each said substituent is def...  
WO/2011/133659
Inhibitors of the Hypoxia Inducible Factor (HIF) and angiogenesis and their methods of use including the treatment of cancer, hypoxia related pathologies, disorders leading to ischemia, for example stroke and ischemic heart disease, and ...  
WO/2011/131881
The invention relates to a method for preparing 3-keto-benzofurane derivatives of the general formula: Formula (I), where R is an alkyl or aryl group, R1 is hydrogen or an alkyl or aryl group, and R2 is a substituted alkyl or phenyl grou...  
WO/2011/128431
Disclosed are novel cross-linkable end-cappers for oligo-and polyimides. End-capped oligo-and polyimides comprising such an end-capper may be cured at a lower temperature compared to oligo-and polyimides end-capped with PEPA.  
WO/2011/129640
The present invention relates to a metal catalyst composition for producing furfural derivatives from raw materials of lignocellulosic biomass, and to a method for producing furfural derivatives using the composition. The metal catalyst ...  
WO/2011/129640
The present invention relates to a metal catalyst composition for producing furfural derivatives from raw materials of lignocellulosic biomass, and to a method for producing furfural derivatives using the composition. The metal catalyst ...  
WO/2011/129640
The present invention relates to a metal catalyst composition for producing furfural derivatives from raw materials of lignocellulosic biomass, and to a method for producing furfural derivatives using the composition. The metal catalyst ...  
WO/2011/128814
In a process for controlling a gas phase oxidation reactor for preparation of phthalic anhydride, by passing a gas stream which comprises an aromatic hydrocarbon and molecular oxygen through a multitude of reaction tubes arranged in the ...  

Matches 701 - 750 out of 14,024